|
Market Closed -
Nasdaq
21:00:00 25/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 44.50 USD | +1.57% |
|
+0.14% | -43.75% |
| 09-10 | Ionis Pharmaceuticals, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-10-2026 08:45 AM | |
| 09-09 | BofA Adjusts Price Target on Ionis Pharmaceuticals to $91 From $93 | MT |
| Market Cap | 7.4B 6.49B 6.13B 5.59B 10.46B 709B 10.53B 73.34B 28.41B 362B 27.77B 27.17B 1,164B | P/E 2026 * |
-12.4x | P/E 2027 * | -22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 7.29B 6.4B 6.04B 5.51B 10.31B 699B 10.38B 72.32B 28.01B 357B 27.38B 26.79B 1,148B | EV / Sales 2026 * |
7.93x | EV / Sales 2027 * | 5.47x |
| Free-Float |
99.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IONS | Delayed | |
CBOE
| IONS | Real-time | |
|
Tradegate
| ISI | Real-time | |
|
London S.E.
| 0JDI | Delayed | |
|
Boerse Muenchen
| ISI | Real-time | |
|
Mexican S.E.
| IONS * | End-of-day quote | |
|
Deutsche Boerse AG
| ISI | Delayed | |
|
Börse Stuttgart
| ISI | Delayed | |
|
Borsa Italiana
| 1IONS | End-of-day quote | |
|
Xetra
| ISI | Delayed |
Last Transcript: Ionis Pharmaceuticals, Inc.
| 1 day | +1.57% | ||
| 1 week | +0.14% | ||
| Current month | -26.28% | ||
| 1 month | -29.77% | ||
| 3 months | -45.18% | ||
| 6 months | -40.06% | ||
| Current year | -43.75% |
| 1 week | 43.01 |  | 46.41 |
| 1 month | 43.01 | | 61.77 |
| Current year | 43.01 | | 86.74 |
| 1 year | 43.01 | | 86.74 |
| 3 years | 23.95 | | 86.74 |
| 5 years | 23.95 | | 86.74 |
| 10 years | 23.95 | | 86.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 30/06/2012 |
Brett Monia
CEO | Chief Executive Officer | 64 | 31/12/2019 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 30/04/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Klein
BRD | Director/Board Member | 64 | 12/12/2005 |
| Director/Board Member | 73 | 30/04/2002 | |
Brett Monia
BRD | Director/Board Member | 64 | 24/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Others | Chief Technology Officer | 110 | 0.0001% | ||
| 31/08/26 | Others | Executive/Senior Manager | 58 | 0.0000% | ||
| 31/08/26 | Others | Founder | 98 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.57% | +0.14% | -30.57% | -3.85% | 7.4B | |
| -0.14% | +4.33% | +9.00% | +31.64% | 47.97B | |
| -1.69% | +1.48% | +50.57% | +34.53% | 44.5B | |
| +2.56% | +7.34% | +366.69% | +608.26% | 43.93B | |
| +0.24% | +2.85% | +10.67% | +94.47% | 41.03B | |
| -0.62% | -1.11% | +4.65% | +48.91% | 29.85B | |
| -0.28% | +1.07% | +24.58% | +155.58% | 17.27B | |
| +3.37% | +9.21% | +8.32% | - | 15.34B | |
| -0.46% | +1.20% | +26.90% | +42.21% | 15.3B | |
| -2.21% | -4.70% | - | - | 14.82B | |
| Average | +0.23% | +2.13% | +52.31% | +126.47% | 27.74B | |
| Weighted average by Cap. | +0.15% | +2.79% | +76.57% | +155.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 920M 807M 762M 694M 1.3B 88.13B 1.31B 9.12B 3.53B 45.03B 3.45B 3.38B 145B | 1.36B 1.2B 1.13B 1.03B 1.93B 131B 1.94B 13.53B 5.24B 66.82B 5.12B 5.01B 215B |
| Net income | -576M -506M -478M -435M -815M -55.23B -821M -5.71B -2.21B -28.22B -2.16B -2.12B -90.68B | -330M -290M -274M -249M -467M -31.65B -470M -3.27B -1.27B -16.17B -1.24B -1.21B -51.96B |
| Net Debt | -103M -90.37M -85.35M -77.78M -146M -9.87B -147M -1.02B -396M -5.04B -387M -378M -16.21B | 68.31M 59.94M 56.61M 51.59M 96.57M 6.55B 97.26M 677M 262M 3.34B 256M 251M 10.75B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | US$44.50 | +1.57% | 6,202,420 |
| 24/09/26 | US$43.81 | -0.27% | 6,448,795 |
| 23/09/26 | US$43.93 | -3.98% | 3,535,786 |
| 22/09/26 | US$45.75 | +1.89% | 4,236,217 |
| 21/09/26 | US$44.90 | +1.04% | 4,521,358 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
